STOCK TITAN

Enzo Biochem Stock Price, News & Analysis

ENZ NYSE

Company Description

Overview of Enzo Biochem Inc

Enzo Biochem Inc (symbol: ENZ) is a globally recognized bioscience company that specializes in molecular diagnostics and the development of innovative technical platforms for the life sciences sector. With a rich history spanning over 45 years, the company focuses on the design, manufacture, and distribution of a comprehensive portfolio of high-quality products. These include antibodies, genomic probes, assays, biochemicals, and proteins, which are integral to a wide array of biomedical research and translational science projects.

Core Business and Product Offerings

The company operates primarily through its single reportable segment, Products, which encompasses advanced labeling and detection technologies used for DNA through to whole cell analysis. Its product range is engineered to meet the rigorous demands of clinical laboratories, specialty clinics, research institutions, and physicians. By leveraging proprietary solutions, Enzo Biochem supports critical areas of cell biology, genomics, immunohistochemistry, and small molecule chemistry. This technical specialization enables researchers and drug developers to accelerate scientific discovery and improve diagnostic accuracy.

Market Position and Industry Impact

Enzo Biochem holds a significant position in the competitive life sciences industry. Its strategic focus on innovation and quality has allowed it to secure a stable foothold within this technically demanding market. The company differentiates itself by its ability to provide reliable, high-performance reagents and detection systems that meet the evolving needs of translational research and drug development. This robust market position is underpinned by a deep intellectual property portfolio that safeguards its enabling technologies and fosters continuous innovation.

Business Model and Revenue Generation

The firm generates revenue primarily through direct sales within a global distribution network and through licensing agreements that extend its proprietary technology to a broad spectrum of research and clinical applications. The emphasis on operational conservatism combined with focused market segmentation allows the company to manage its resources efficiently while supporting substantial growth within its core life science division.

Technical Expertise and Research Integration

Enzo Biochem demonstrates technical excellence through its sustained commitment to research and development. The company’s extensive portfolio is a testament to its dedication to enabling advanced scientific methodologies. By consistently incorporating state-of-the-art technologies and partnering with leading research centers, Enzo Biochem empowers the medical and research communities to translate lab discoveries into clinically relevant applications.

Customer and Global Reach

Serving a diverse global clientele, Enzo Biochem’s products are used by clinical laboratories, specialty clinics, and research organizations across continents. The company’s reliable performance and commitment to quality have made it a trusted supplier for scientists and healthcare providers engaged in fundamental research, drug discovery, and translational science. Its strategic geographic positioning, including its executive hub in Farmingdale, New York, supports robust communication and distribution networks.

Operational Philosophy and Industry Insights

Enzo Biochem’s operational philosophy is characterized by technical strength, market focus, and conservatism in its financial practices. This approach enables the company to deliver products that are not only innovative but also consistently meet the high standards required for cutting-edge laboratory research. Through a balanced emphasis on technical precision and stringent quality control, Enzo Biochem remains committed to advancing the frontiers of biomedical research globally.

Key Takeaways

  • Comprehensive Product Portfolio: From antibodies to genomic probes, every product is designed to support detailed molecular analysis.
  • Innovative Platforms: Proprietary technologies and reagent sets drive advancements in molecular diagnostics and translational research.
  • Global Distribution and Licensing: A robust business model that leverages both direct sales and licensing opportunities.
  • Research Integration: Support for cutting-edge biomedical research across diverse regions and institutions.
  • Intellectual Property Strength: A deep portfolio of patents and proprietary technologies that secure its market position.

This detailed overview of Enzo Biochem Inc provides investors, industry analysts, and researchers with an authoritative narrative on the company’s operations, market dynamics, and contribution to advancing healthcare and scientific innovation.

Stock Performance

$—
0.00%
0.00
Last updated:
-52.38 %
Performance 1 year
$18.3M
Market Cap
52.4M
Shares outstanding

SEC Filings

No SEC filings available for Enzo Biochem.

Financial Highlights

$7,334,000
Revenue (TTM)
-$1,535,000
Net Income (TTM)
-$0.03
Diluted EPS (TTM)
-$2,026,000
Operating Cash Flow
-20.93%
Net Profit Margin
-21.84%
Oper. Profit Margin

Upcoming Events

Frequently Asked Questions

What is the current stock price of Enzo Biochem (ENZ)?

The current stock price of Enzo Biochem (ENZ) is $0.3138 as of April 21, 2025.

What is the market cap of Enzo Biochem (ENZ)?

The market cap of Enzo Biochem (ENZ) is approximately 18.3M.

What is the revenue (TTM) of Enzo Biochem (ENZ) stock?

The trailing twelve months (TTM) revenue of Enzo Biochem (ENZ) is $7,334,000.

What is the net income of Enzo Biochem (ENZ)?

The trailing twelve months (TTM) net income of Enzo Biochem (ENZ) is -$1,535,000.

What is the earnings per share (EPS) of Enzo Biochem (ENZ)?

The diluted earnings per share (EPS) of Enzo Biochem (ENZ) is -$0.03 on a trailing twelve months (TTM) basis.

What is the operating cash flow of Enzo Biochem (ENZ)?

The operating cash flow of Enzo Biochem (ENZ) is -$2,026,000.

What is the profit margin of Enzo Biochem (ENZ)?

The net profit margin of Enzo Biochem (ENZ) is -20.93%.

What is the operating margin of Enzo Biochem (ENZ)?

The operating profit margin of Enzo Biochem (ENZ) is -21.84%.

What is the gross margin of Enzo Biochem (ENZ)?

The gross profit margin of Enzo Biochem (ENZ) is 146.74%.

What is the current ratio of Enzo Biochem (ENZ)?

The current ratio of Enzo Biochem (ENZ) is 3.04, indicating the company's ability to pay short-term obligations.

What is the gross profit of Enzo Biochem (ENZ)?

The gross profit of Enzo Biochem (ENZ) is $10,762,000 on a trailing twelve months (TTM) basis.

What is the operating income of Enzo Biochem (ENZ)?

The operating income of Enzo Biochem (ENZ) is -$1,602,000.

What is the primary business of Enzo Biochem Inc?

Enzo Biochem Inc is a bioscience company that develops, manufactures, and sells proprietary diagnostic and research solutions including antibodies, genomic probes, and assays.

What markets does Enzo Biochem primarily serve?

The company serves clinical laboratories, specialty clinics, research institutions, and physicians by providing advanced labeling and detection technologies.

How does Enzo Biochem generate its revenue?

Revenue is generated through direct sales of its extensive product portfolio via a global distribution network and through strategic licensing of its proprietary technologies.

What distinguishes Enzo Biochem from its competitors?

Enzo Biochem is distinguished by its comprehensive portfolio, deep intellectual property portfolio, and its commitment to integrating innovative technologies in molecular diagnostics and translational research.

How does the company support biomedical research and drug development?

Its high-quality products, including reagents and detection systems, play a critical role in supporting translational research and drug development by enabling precise molecular and cellular analysis.

What are the core technical areas Enzo Biochem focuses on?

The company focuses on key areas such as cell biology, genomics, immunohistochemistry, and small molecule chemistry, providing essential tools for advanced biomedical research.